Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoreactive Trypsinogen in Infants With Intestinal Perforation

NCT01530828 is registered in ClinicalTrials.gov with Children's Hospitals and Clinics of Minnesota as lead sponsor.

NCT NCT01530828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01530828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoreactive Trypsinogen in Infants With Intestinal Perforation
Lead sponsor
Children's Hospitals and Clinics of Minnesota
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
August 31, 2014
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal perforation, necrotizing enterocolitis